nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Ipratropium bromide—asthma	0.496	1	CrCtD
Methylphenidate—Dexmethylphenidate—Ipratropium bromide—asthma	0.0755	0.259	CrCrCtD
Methylphenidate—Cyclandelate—Ipratropium bromide—asthma	0.0585	0.201	CrCrCtD
Methylphenidate—Homatropine Methylbromide—Ipratropium bromide—asthma	0.0546	0.188	CrCrCtD
Methylphenidate—Atropine—Ipratropium bromide—asthma	0.0512	0.176	CrCrCtD
Methylphenidate—Hyoscyamine—Ipratropium bromide—asthma	0.0512	0.176	CrCrCtD
Methylphenidate—CYP2D6—Ciclesonide—asthma	0.0171	0.17	CbGbCtD
Methylphenidate—CYP2D6—Ipratropium bromide—asthma	0.0142	0.141	CbGbCtD
Methylphenidate—CYP2D6—Zafirlukast—asthma	0.0125	0.124	CbGbCtD
Methylphenidate—CYP2D6—Arformoterol—asthma	0.0121	0.12	CbGbCtD
Methylphenidate—CYP2D6—Formoterol—asthma	0.0121	0.12	CbGbCtD
Methylphenidate—CYP2D6—Tiotropium—asthma	0.0107	0.107	CbGbCtD
Methylphenidate—CYP2D6—Theophylline—asthma	0.00964	0.0958	CbGbCtD
Methylphenidate—CYP2D6—Loratadine—asthma	0.00914	0.0909	CbGbCtD
Methylphenidate—CYP2D6—Dexamethasone—asthma	0.00316	0.0314	CbGbCtD
Methylphenidate—SLC6A4—Serotonin Transporter Activity—IL1R1—asthma	0.000273	0.0906	CbGpPWpGaD
Methylphenidate—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—asthma	0.000209	0.0692	CbGpPWpGaD
Methylphenidate—SLC6A4—Serotonin Transporter Activity—NOS1—asthma	0.000166	0.0549	CbGpPWpGaD
Methylphenidate—SLC6A4—Synaptic Vesicle Pathway—SLC18A3—asthma	0.000128	0.0423	CbGpPWpGaD
Methylphenidate—SLC6A4—Monoamine Transport—IL1R1—asthma	0.000116	0.0385	CbGpPWpGaD
Methylphenidate—SLC6A2—Monoamine Transport—IL1R1—asthma	0.0001	0.0331	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—IL1R1—asthma	8.86e-05	0.0294	CbGpPWpGaD
Methylphenidate—SLC6A4—Monoamine Transport—NOS1—asthma	7.04e-05	0.0233	CbGpPWpGaD
Methylphenidate—SLC6A4—Serotonin Transporter Activity—IL1B—asthma	6.75e-05	0.0224	CbGpPWpGaD
Methylphenidate—SLC6A2—Monoamine Transport—NOS1—asthma	6.06e-05	0.0201	CbGpPWpGaD
Methylphenidate—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—asthma	5.62e-05	0.0186	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—NOS1—asthma	5.37e-05	0.0178	CbGpPWpGaD
Methylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—asthma	4.97e-05	0.0165	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—PRMT5—asthma	4.44e-05	0.0147	CbGpPWpGaD
Methylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—asthma	4.4e-05	0.0146	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—SLC18A3—asthma	3.26e-05	0.0108	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—HNMT—asthma	3.23e-05	0.0107	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—CHAT—asthma	3.12e-05	0.0104	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—MYB—asthma	2.88e-05	0.00955	CbGpPWpGaD
Methylphenidate—SLC6A4—Monoamine Transport—IL1B—asthma	2.87e-05	0.00952	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—TACR1—asthma	2.78e-05	0.00923	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—SERPINA1—asthma	2.76e-05	0.00915	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—PRF1—asthma	2.67e-05	0.00886	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—UTS2—asthma	2.55e-05	0.00845	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—SLC18A3—asthma	2.49e-05	0.00827	CbGpPWpGaD
Methylphenidate—SLC6A2—Monoamine Transport—IL1B—asthma	2.47e-05	0.00819	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—asthma	2.47e-05	0.00818	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL13—asthma	2.47e-05	0.00817	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—SERPINA1—asthma	2.37e-05	0.00787	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—TAC1—asthma	2.27e-05	0.00752	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC30A8—asthma	2.26e-05	0.00748	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—GATA3—asthma	2.23e-05	0.00738	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—IL1B—asthma	2.19e-05	0.00726	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—asthma	2.19e-05	0.00725	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—TRPA1—asthma	2.18e-05	0.00724	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1RN—asthma	2.16e-05	0.00714	CbGpPWpGaD
Methylphenidate—CYP2D6—Melatonin metabolism and effects—EDN1—asthma	2.14e-05	0.00709	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—NQO1—asthma	2.12e-05	0.00703	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—SERPINA1—asthma	2.1e-05	0.00697	CbGpPWpGaD
Methylphenidate—SLC6A4—Monoamine Transport—TNF—asthma	2.09e-05	0.00691	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC30A8—asthma	2e-05	0.00663	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—ESR2—asthma	2e-05	0.00662	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—CHAT—asthma	1.95e-05	0.00647	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—TRPA1—asthma	1.94e-05	0.00641	CbGpPWpGaD
Methylphenidate—SLC6A3—Dopaminergic Neurogenesis—STAT3—asthma	1.93e-05	0.0064	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—NPS—asthma	1.85e-05	0.00614	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—NQO1—asthma	1.83e-05	0.00605	CbGpPWpGaD
Methylphenidate—SLC6A2—Monoamine Transport—TNF—asthma	1.79e-05	0.00594	CbGpPWpGaD
Methylphenidate—SLC6A3—Dopaminergic Neurogenesis—TGFB1—asthma	1.79e-05	0.00594	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—GSTP1—asthma	1.77e-05	0.00587	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—HMOX1—asthma	1.75e-05	0.00579	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—GSTM1—asthma	1.63e-05	0.00539	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—NQO1—asthma	1.62e-05	0.00536	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—BDNF—asthma	1.62e-05	0.00536	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—ALDH2—asthma	1.59e-05	0.00527	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—TNF—asthma	1.59e-05	0.00526	CbGpPWpGaD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—asthma	1.58e-05	0.00524	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—AGER—asthma	1.57e-05	0.0052	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL10—asthma	1.54e-05	0.00511	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—GSTP1—asthma	1.52e-05	0.00505	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—HMOX1—asthma	1.5e-05	0.00498	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—CHAT—asthma	1.49e-05	0.00495	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—NTRK1—asthma	1.44e-05	0.00478	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—NR3C1—asthma	1.43e-05	0.00473	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—PDGFB—asthma	1.4e-05	0.00464	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—GSTM1—asthma	1.4e-05	0.00464	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—AGER—asthma	1.35e-05	0.00447	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—GSTP1—asthma	1.35e-05	0.00447	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—HMOX1—asthma	1.33e-05	0.00441	CbGpPWpGaD
Methylphenidate—Cough—Triamcinolone—asthma	1.27e-05	0.000117	CcSEcCtD
Methylphenidate—Anaphylactic shock—Hydrocortisone—asthma	1.27e-05	0.000116	CcSEcCtD
Methylphenidate—Oedema—Hydrocortisone—asthma	1.27e-05	0.000116	CcSEcCtD
Methylphenidate—Convulsion—Triamcinolone—asthma	1.26e-05	0.000116	CcSEcCtD
Methylphenidate—Tachycardia—Prednisolone—asthma	1.26e-05	0.000116	CcSEcCtD
Methylphenidate—Convulsion—Methylprednisolone—asthma	1.26e-05	0.000115	CcSEcCtD
Methylphenidate—Hypertension—Triamcinolone—asthma	1.26e-05	0.000115	CcSEcCtD
Methylphenidate—Hypertension—Methylprednisolone—asthma	1.26e-05	0.000115	CcSEcCtD
Methylphenidate—Infection—Hydrocortisone—asthma	1.26e-05	0.000115	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC26A4—asthma	1.25e-05	0.00416	CbGpPWpGaD
Methylphenidate—Hyperhidrosis—Prednisolone—asthma	1.25e-05	0.000115	CcSEcCtD
Methylphenidate—Shock—Hydrocortisone—asthma	1.24e-05	0.000114	CcSEcCtD
Methylphenidate—Myalgia—Triamcinolone—asthma	1.24e-05	0.000114	CcSEcCtD
Methylphenidate—Nervous system disorder—Hydrocortisone—asthma	1.24e-05	0.000114	CcSEcCtD
Methylphenidate—Myalgia—Methylprednisolone—asthma	1.24e-05	0.000113	CcSEcCtD
Methylphenidate—Arthralgia—Methylprednisolone—asthma	1.24e-05	0.000113	CcSEcCtD
Methylphenidate—SLC6A3—NRF2 pathway—GSTM1—asthma	1.24e-05	0.00411	CbGpPWpGaD
Methylphenidate—Eye disorder—Prednisone—asthma	1.24e-05	0.000113	CcSEcCtD
Methylphenidate—Anxiety—Methylprednisolone—asthma	1.24e-05	0.000113	CcSEcCtD
Methylphenidate—Tachycardia—Hydrocortisone—asthma	1.23e-05	0.000113	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	1.23e-05	0.000113	CcSEcCtD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—ADCY2—asthma	1.23e-05	0.00408	CbGpPWpGaD
Methylphenidate—Flushing—Prednisone—asthma	1.23e-05	0.000113	CcSEcCtD
Methylphenidate—Skin disorder—Hydrocortisone—asthma	1.23e-05	0.000112	CcSEcCtD
Methylphenidate—Ill-defined disorder—Dexamethasone—asthma	1.23e-05	0.000112	CcSEcCtD
Methylphenidate—Ill-defined disorder—Betamethasone—asthma	1.23e-05	0.000112	CcSEcCtD
Methylphenidate—Discomfort—Triamcinolone—asthma	1.23e-05	0.000112	CcSEcCtD
Methylphenidate—Discomfort—Methylprednisolone—asthma	1.23e-05	0.000112	CcSEcCtD
Methylphenidate—Hyperhidrosis—Hydrocortisone—asthma	1.22e-05	0.000112	CcSEcCtD
Methylphenidate—SLC6A3—Neuronal System—ALDH2—asthma	1.22e-05	0.00404	CbGpPWpGaD
Methylphenidate—Dry mouth—Triamcinolone—asthma	1.22e-05	0.000111	CcSEcCtD
Methylphenidate—Angioedema—Dexamethasone—asthma	1.21e-05	0.000111	CcSEcCtD
Methylphenidate—Angioedema—Betamethasone—asthma	1.21e-05	0.000111	CcSEcCtD
Methylphenidate—Anorexia—Hydrocortisone—asthma	1.21e-05	0.00011	CcSEcCtD
Methylphenidate—SLC6A2—NRF2 pathway—PDGFB—asthma	1.2e-05	0.00399	CbGpPWpGaD
Methylphenidate—Angiopathy—Prednisone—asthma	1.2e-05	0.00011	CcSEcCtD
Methylphenidate—Confusional state—Methylprednisolone—asthma	1.2e-05	0.00011	CcSEcCtD
Methylphenidate—Immune system disorder—Prednisone—asthma	1.2e-05	0.00011	CcSEcCtD
Methylphenidate—SLC6A3—NRF2 pathway—AGER—asthma	1.19e-05	0.00396	CbGpPWpGaD
Methylphenidate—Malaise—Dexamethasone—asthma	1.19e-05	0.000109	CcSEcCtD
Methylphenidate—Malaise—Betamethasone—asthma	1.19e-05	0.000109	CcSEcCtD
Methylphenidate—Oedema—Triamcinolone—asthma	1.19e-05	0.000109	CcSEcCtD
Methylphenidate—Anaphylactic shock—Triamcinolone—asthma	1.19e-05	0.000109	CcSEcCtD
Methylphenidate—Vertigo—Betamethasone—asthma	1.19e-05	0.000109	CcSEcCtD
Methylphenidate—Vertigo—Dexamethasone—asthma	1.19e-05	0.000109	CcSEcCtD
Methylphenidate—Anaphylactic shock—Methylprednisolone—asthma	1.19e-05	0.000109	CcSEcCtD
Methylphenidate—Syncope—Betamethasone—asthma	1.19e-05	0.000109	CcSEcCtD
Methylphenidate—Syncope—Dexamethasone—asthma	1.19e-05	0.000109	CcSEcCtD
Methylphenidate—Arrhythmia—Prednisone—asthma	1.18e-05	0.000108	CcSEcCtD
Methylphenidate—Infection—Triamcinolone—asthma	1.18e-05	0.000108	CcSEcCtD
Methylphenidate—Infection—Methylprednisolone—asthma	1.18e-05	0.000108	CcSEcCtD
Methylphenidate—Shock—Triamcinolone—asthma	1.17e-05	0.000107	CcSEcCtD
Methylphenidate—Insomnia—Prednisolone—asthma	1.17e-05	0.000107	CcSEcCtD
Methylphenidate—Alopecia—Prednisone—asthma	1.17e-05	0.000107	CcSEcCtD
Methylphenidate—Shock—Methylprednisolone—asthma	1.17e-05	0.000107	CcSEcCtD
Methylphenidate—Nervous system disorder—Methylprednisolone—asthma	1.17e-05	0.000107	CcSEcCtD
Methylphenidate—Loss of consciousness—Betamethasone—asthma	1.16e-05	0.000107	CcSEcCtD
Methylphenidate—Loss of consciousness—Dexamethasone—asthma	1.16e-05	0.000107	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisolone—asthma	1.16e-05	0.000106	CcSEcCtD
Methylphenidate—Tachycardia—Triamcinolone—asthma	1.16e-05	0.000106	CcSEcCtD
Methylphenidate—Mental disorder—Prednisone—asthma	1.16e-05	0.000106	CcSEcCtD
Methylphenidate—Tachycardia—Methylprednisolone—asthma	1.16e-05	0.000106	CcSEcCtD
Methylphenidate—Skin disorder—Methylprednisolone—asthma	1.15e-05	0.000106	CcSEcCtD
Methylphenidate—Erythema—Prednisone—asthma	1.15e-05	0.000106	CcSEcCtD
Methylphenidate—Malnutrition—Prednisone—asthma	1.15e-05	0.000106	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Hydrocortisone—asthma	1.15e-05	0.000105	CcSEcCtD
Methylphenidate—Hyperhidrosis—Triamcinolone—asthma	1.15e-05	0.000105	CcSEcCtD
Methylphenidate—Hyperhidrosis—Methylprednisolone—asthma	1.15e-05	0.000105	CcSEcCtD
Methylphenidate—Convulsion—Dexamethasone—asthma	1.15e-05	0.000105	CcSEcCtD
Methylphenidate—Convulsion—Betamethasone—asthma	1.15e-05	0.000105	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—ATP4A—asthma	1.15e-05	0.0038	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC30A8—asthma	1.15e-05	0.0038	CbGpPWpGaD
Methylphenidate—Insomnia—Hydrocortisone—asthma	1.14e-05	0.000105	CcSEcCtD
Methylphenidate—Hypertension—Betamethasone—asthma	1.14e-05	0.000105	CcSEcCtD
Methylphenidate—Hypertension—Dexamethasone—asthma	1.14e-05	0.000105	CcSEcCtD
Methylphenidate—Paraesthesia—Hydrocortisone—asthma	1.14e-05	0.000104	CcSEcCtD
Methylphenidate—Myalgia—Betamethasone—asthma	1.13e-05	0.000103	CcSEcCtD
Methylphenidate—Myalgia—Dexamethasone—asthma	1.13e-05	0.000103	CcSEcCtD
Methylphenidate—Anxiety—Dexamethasone—asthma	1.12e-05	0.000103	CcSEcCtD
Methylphenidate—Anxiety—Betamethasone—asthma	1.12e-05	0.000103	CcSEcCtD
Methylphenidate—Discomfort—Betamethasone—asthma	1.11e-05	0.000102	CcSEcCtD
Methylphenidate—Discomfort—Dexamethasone—asthma	1.11e-05	0.000102	CcSEcCtD
Methylphenidate—Dyspepsia—Hydrocortisone—asthma	1.11e-05	0.000102	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC26A4—asthma	1.11e-05	0.00368	CbGpPWpGaD
Methylphenidate—Pain—Prednisolone—asthma	1.11e-05	0.000101	CcSEcCtD
Methylphenidate—Decreased appetite—Hydrocortisone—asthma	1.1e-05	0.000101	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Hydrocortisone—asthma	1.09e-05	0.0001	CcSEcCtD
Methylphenidate—Fatigue—Hydrocortisone—asthma	1.09e-05	9.98e-05	CcSEcCtD
Methylphenidate—Vision blurred—Prednisone—asthma	1.09e-05	9.95e-05	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Triamcinolone—asthma	1.09e-05	9.93e-05	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Methylprednisolone—asthma	1.08e-05	9.91e-05	CcSEcCtD
Methylphenidate—Pain—Hydrocortisone—asthma	1.08e-05	9.9e-05	CcSEcCtD
Methylphenidate—Anaphylactic shock—Dexamethasone—asthma	1.08e-05	9.89e-05	CcSEcCtD
Methylphenidate—Anaphylactic shock—Betamethasone—asthma	1.08e-05	9.89e-05	CcSEcCtD
Methylphenidate—Oedema—Betamethasone—asthma	1.08e-05	9.89e-05	CcSEcCtD
Methylphenidate—Oedema—Dexamethasone—asthma	1.08e-05	9.89e-05	CcSEcCtD
Methylphenidate—Insomnia—Triamcinolone—asthma	1.08e-05	9.86e-05	CcSEcCtD
Methylphenidate—Insomnia—Methylprednisolone—asthma	1.08e-05	9.84e-05	CcSEcCtD
Methylphenidate—Infection—Betamethasone—asthma	1.07e-05	9.83e-05	CcSEcCtD
Methylphenidate—Infection—Dexamethasone—asthma	1.07e-05	9.83e-05	CcSEcCtD
Methylphenidate—Ill-defined disorder—Prednisone—asthma	1.07e-05	9.79e-05	CcSEcCtD
Methylphenidate—Paraesthesia—Triamcinolone—asthma	1.07e-05	9.79e-05	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisolone—asthma	1.07e-05	9.77e-05	CcSEcCtD
Methylphenidate—Paraesthesia—Methylprednisolone—asthma	1.07e-05	9.77e-05	CcSEcCtD
Methylphenidate—Anaemia—Prednisone—asthma	1.07e-05	9.76e-05	CcSEcCtD
Methylphenidate—SLC6A3—NRF2 pathway—PDGFB—asthma	1.07e-05	0.00353	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL6R—asthma	1.06e-05	0.00353	CbGpPWpGaD
Methylphenidate—Shock—Betamethasone—asthma	1.06e-05	9.73e-05	CcSEcCtD
Methylphenidate—Shock—Dexamethasone—asthma	1.06e-05	9.73e-05	CcSEcCtD
Methylphenidate—Dyspnoea—Triamcinolone—asthma	1.06e-05	9.72e-05	CcSEcCtD
Methylphenidate—Nervous system disorder—Betamethasone—asthma	1.06e-05	9.7e-05	CcSEcCtD
Methylphenidate—Nervous system disorder—Dexamethasone—asthma	1.06e-05	9.7e-05	CcSEcCtD
Methylphenidate—Agitation—Prednisone—asthma	1.06e-05	9.7e-05	CcSEcCtD
Methylphenidate—Thrombocytopenia—Betamethasone—asthma	1.06e-05	9.69e-05	CcSEcCtD
Methylphenidate—Thrombocytopenia—Dexamethasone—asthma	1.06e-05	9.69e-05	CcSEcCtD
Methylphenidate—Tachycardia—Dexamethasone—asthma	1.05e-05	9.66e-05	CcSEcCtD
Methylphenidate—Tachycardia—Betamethasone—asthma	1.05e-05	9.66e-05	CcSEcCtD
Methylphenidate—Angioedema—Prednisone—asthma	1.05e-05	9.65e-05	CcSEcCtD
Methylphenidate—Dyspepsia—Triamcinolone—asthma	1.05e-05	9.6e-05	CcSEcCtD
Methylphenidate—Dyspepsia—Methylprednisolone—asthma	1.05e-05	9.58e-05	CcSEcCtD
Methylphenidate—Hyperhidrosis—Betamethasone—asthma	1.04e-05	9.56e-05	CcSEcCtD
Methylphenidate—Hyperhidrosis—Dexamethasone—asthma	1.04e-05	9.56e-05	CcSEcCtD
Methylphenidate—Feeling abnormal—Hydrocortisone—asthma	1.04e-05	9.54e-05	CcSEcCtD
Methylphenidate—Malaise—Prednisone—asthma	1.04e-05	9.52e-05	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—LEP—asthma	1.04e-05	0.00343	CbGpPWpGaD
Methylphenidate—Vertigo—Prednisone—asthma	1.04e-05	9.48e-05	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Hydrocortisone—asthma	1.03e-05	9.47e-05	CcSEcCtD
Methylphenidate—Syncope—Prednisone—asthma	1.03e-05	9.47e-05	CcSEcCtD
Methylphenidate—Anorexia—Dexamethasone—asthma	1.03e-05	9.43e-05	CcSEcCtD
Methylphenidate—Anorexia—Betamethasone—asthma	1.03e-05	9.43e-05	CcSEcCtD
Methylphenidate—Urticaria—Prednisolone—asthma	1.03e-05	9.42e-05	CcSEcCtD
Methylphenidate—Fatigue—Triamcinolone—asthma	1.03e-05	9.4e-05	CcSEcCtD
Methylphenidate—Fatigue—Methylprednisolone—asthma	1.02e-05	9.38e-05	CcSEcCtD
Methylphenidate—Pain—Triamcinolone—asthma	1.02e-05	9.32e-05	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—ATP4A—asthma	1.02e-05	0.00337	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC30A8—asthma	1.02e-05	0.00337	CbGpPWpGaD
Methylphenidate—Loss of consciousness—Prednisone—asthma	1.01e-05	9.28e-05	CcSEcCtD
Methylphenidate—Urticaria—Hydrocortisone—asthma	1.01e-05	9.2e-05	CcSEcCtD
Methylphenidate—Body temperature increased—Hydrocortisone—asthma	1e-05	9.15e-05	CcSEcCtD
Methylphenidate—Abdominal pain—Hydrocortisone—asthma	1e-05	9.15e-05	CcSEcCtD
Methylphenidate—Convulsion—Prednisone—asthma	9.99e-06	9.15e-05	CcSEcCtD
Methylphenidate—Hypertension—Prednisone—asthma	9.96e-06	9.11e-05	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Betamethasone—asthma	9.85e-06	9.01e-05	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Dexamethasone—asthma	9.85e-06	9.01e-05	CcSEcCtD
Methylphenidate—Arthralgia—Prednisone—asthma	9.82e-06	8.99e-05	CcSEcCtD
Methylphenidate—Myalgia—Prednisone—asthma	9.82e-06	8.99e-05	CcSEcCtD
Methylphenidate—Feeling abnormal—Triamcinolone—asthma	9.82e-06	8.98e-05	CcSEcCtD
Methylphenidate—Feeling abnormal—Methylprednisolone—asthma	9.8e-06	8.96e-05	CcSEcCtD
Methylphenidate—Anxiety—Prednisone—asthma	9.79e-06	8.96e-05	CcSEcCtD
Methylphenidate—Insomnia—Betamethasone—asthma	9.78e-06	8.95e-05	CcSEcCtD
Methylphenidate—Insomnia—Dexamethasone—asthma	9.78e-06	8.95e-05	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	9.75e-06	8.93e-05	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Methylprednisolone—asthma	9.72e-06	8.9e-05	CcSEcCtD
Methylphenidate—Paraesthesia—Dexamethasone—asthma	9.71e-06	8.88e-05	CcSEcCtD
Methylphenidate—Paraesthesia—Betamethasone—asthma	9.71e-06	8.88e-05	CcSEcCtD
Methylphenidate—Discomfort—Prednisone—asthma	9.7e-06	8.88e-05	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—NOS2—asthma	9.66e-06	0.0032	CbGpPWpGaD
Methylphenidate—Hypersensitivity—Prednisolone—asthma	9.54e-06	8.73e-05	CcSEcCtD
Methylphenidate—Dyspepsia—Dexamethasone—asthma	9.52e-06	8.71e-05	CcSEcCtD
Methylphenidate—Dyspepsia—Betamethasone—asthma	9.52e-06	8.71e-05	CcSEcCtD
Methylphenidate—Urticaria—Triamcinolone—asthma	9.46e-06	8.66e-05	CcSEcCtD
Methylphenidate—Urticaria—Methylprednisolone—asthma	9.44e-06	8.64e-05	CcSEcCtD
Methylphenidate—SLC6A3—Neuronal System—ADCY2—asthma	9.42e-06	0.00312	CbGpPWpGaD
Methylphenidate—Body temperature increased—Triamcinolone—asthma	9.42e-06	8.62e-05	CcSEcCtD
Methylphenidate—Oedema—Prednisone—asthma	9.41e-06	8.62e-05	CcSEcCtD
Methylphenidate—Anaphylactic shock—Prednisone—asthma	9.41e-06	8.62e-05	CcSEcCtD
Methylphenidate—Abdominal pain—Methylprednisolone—asthma	9.4e-06	8.6e-05	CcSEcCtD
Methylphenidate—Decreased appetite—Betamethasone—asthma	9.4e-06	8.6e-05	CcSEcCtD
Methylphenidate—Decreased appetite—Dexamethasone—asthma	9.4e-06	8.6e-05	CcSEcCtD
Methylphenidate—Infection—Prednisone—asthma	9.35e-06	8.56e-05	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Betamethasone—asthma	9.33e-06	8.54e-05	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Dexamethasone—asthma	9.33e-06	8.54e-05	CcSEcCtD
Methylphenidate—Hypersensitivity—Hydrocortisone—asthma	9.32e-06	8.53e-05	CcSEcCtD
Methylphenidate—Fatigue—Dexamethasone—asthma	9.32e-06	8.53e-05	CcSEcCtD
Methylphenidate—Fatigue—Betamethasone—asthma	9.32e-06	8.53e-05	CcSEcCtD
Methylphenidate—Shock—Prednisone—asthma	9.26e-06	8.48e-05	CcSEcCtD
Methylphenidate—Pain—Dexamethasone—asthma	9.24e-06	8.46e-05	CcSEcCtD
Methylphenidate—Pain—Betamethasone—asthma	9.24e-06	8.46e-05	CcSEcCtD
Methylphenidate—Nervous system disorder—Prednisone—asthma	9.23e-06	8.45e-05	CcSEcCtD
Methylphenidate—Tachycardia—Prednisone—asthma	9.19e-06	8.41e-05	CcSEcCtD
Methylphenidate—Skin disorder—Prednisone—asthma	9.14e-06	8.37e-05	CcSEcCtD
Methylphenidate—Hyperhidrosis—Prednisone—asthma	9.1e-06	8.33e-05	CcSEcCtD
Methylphenidate—Asthenia—Hydrocortisone—asthma	9.08e-06	8.31e-05	CcSEcCtD
Methylphenidate—Anorexia—Prednisone—asthma	8.97e-06	8.21e-05	CcSEcCtD
Methylphenidate—Pruritus—Hydrocortisone—asthma	8.95e-06	8.19e-05	CcSEcCtD
Methylphenidate—Feeling abnormal—Dexamethasone—asthma	8.91e-06	8.15e-05	CcSEcCtD
Methylphenidate—Feeling abnormal—Betamethasone—asthma	8.91e-06	8.15e-05	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Betamethasone—asthma	8.84e-06	8.09e-05	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Dexamethasone—asthma	8.84e-06	8.09e-05	CcSEcCtD
Methylphenidate—Hypersensitivity—Triamcinolone—asthma	8.78e-06	8.03e-05	CcSEcCtD
Methylphenidate—Hypersensitivity—Methylprednisolone—asthma	8.76e-06	8.01e-05	CcSEcCtD
Methylphenidate—Diarrhoea—Hydrocortisone—asthma	8.66e-06	7.92e-05	CcSEcCtD
Methylphenidate—Urticaria—Dexamethasone—asthma	8.59e-06	7.86e-05	CcSEcCtD
Methylphenidate—Urticaria—Betamethasone—asthma	8.59e-06	7.86e-05	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Prednisone—asthma	8.58e-06	7.85e-05	CcSEcCtD
Methylphenidate—Dizziness—Prednisolone—asthma	8.57e-06	7.84e-05	CcSEcCtD
Methylphenidate—Asthenia—Triamcinolone—asthma	8.55e-06	7.82e-05	CcSEcCtD
Methylphenidate—Abdominal pain—Dexamethasone—asthma	8.55e-06	7.82e-05	CcSEcCtD
Methylphenidate—Body temperature increased—Betamethasone—asthma	8.55e-06	7.82e-05	CcSEcCtD
Methylphenidate—Abdominal pain—Betamethasone—asthma	8.55e-06	7.82e-05	CcSEcCtD
Methylphenidate—Body temperature increased—Dexamethasone—asthma	8.55e-06	7.82e-05	CcSEcCtD
Methylphenidate—Asthenia—Methylprednisolone—asthma	8.53e-06	7.81e-05	CcSEcCtD
Methylphenidate—Insomnia—Prednisone—asthma	8.51e-06	7.79e-05	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisone—asthma	8.45e-06	7.74e-05	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—CXCL8—asthma	8.43e-06	0.0028	CbGpPWpGaD
Methylphenidate—Pruritus—Triamcinolone—asthma	8.43e-06	7.71e-05	CcSEcCtD
Methylphenidate—Pruritus—Methylprednisolone—asthma	8.41e-06	7.7e-05	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—ALDH2—asthma	8.4e-06	0.00279	CbGpPWpGaD
Methylphenidate—Dizziness—Hydrocortisone—asthma	8.37e-06	7.66e-05	CcSEcCtD
Methylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—asthma	8.36e-06	0.00277	CbGpPWpGaD
Methylphenidate—Dyspepsia—Prednisone—asthma	8.29e-06	7.58e-05	CcSEcCtD
Methylphenidate—Decreased appetite—Prednisone—asthma	8.18e-06	7.49e-05	CcSEcCtD
Methylphenidate—Rash—Prednisolone—asthma	8.17e-06	7.48e-05	CcSEcCtD
Methylphenidate—Dermatitis—Prednisolone—asthma	8.16e-06	7.47e-05	CcSEcCtD
Methylphenidate—Diarrhoea—Methylprednisolone—asthma	8.13e-06	7.44e-05	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—SERPINE1—asthma	8.13e-06	0.0027	CbGpPWpGaD
Methylphenidate—Fatigue—Prednisone—asthma	8.12e-06	7.43e-05	CcSEcCtD
Methylphenidate—Headache—Prednisolone—asthma	8.12e-06	7.43e-05	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1B—asthma	8.09e-06	0.00268	CbGpPWpGaD
Methylphenidate—Constipation—Prednisone—asthma	8.05e-06	7.37e-05	CcSEcCtD
Methylphenidate—Vomiting—Hydrocortisone—asthma	8.04e-06	7.36e-05	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—GSTT1—asthma	7.99e-06	0.00265	CbGpPWpGaD
Methylphenidate—Rash—Hydrocortisone—asthma	7.98e-06	7.3e-05	CcSEcCtD
Methylphenidate—Dermatitis—Hydrocortisone—asthma	7.97e-06	7.29e-05	CcSEcCtD
Methylphenidate—Headache—Hydrocortisone—asthma	7.93e-06	7.25e-05	CcSEcCtD
Methylphenidate—Dizziness—Triamcinolone—asthma	7.88e-06	7.21e-05	CcSEcCtD
Methylphenidate—Dizziness—Methylprednisolone—asthma	7.86e-06	7.19e-05	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisone—asthma	7.76e-06	7.1e-05	CcSEcCtD
Methylphenidate—Asthenia—Betamethasone—asthma	7.76e-06	7.1e-05	CcSEcCtD
Methylphenidate—Asthenia—Dexamethasone—asthma	7.76e-06	7.1e-05	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—CARM1—asthma	7.71e-06	0.00256	CbGpPWpGaD
Methylphenidate—Gastrointestinal pain—Prednisone—asthma	7.7e-06	7.04e-05	CcSEcCtD
Methylphenidate—Nausea—Prednisolone—asthma	7.69e-06	7.04e-05	CcSEcCtD
Methylphenidate—Pruritus—Dexamethasone—asthma	7.65e-06	7e-05	CcSEcCtD
Methylphenidate—Pruritus—Betamethasone—asthma	7.65e-06	7e-05	CcSEcCtD
Methylphenidate—Vomiting—Triamcinolone—asthma	7.57e-06	6.93e-05	CcSEcCtD
Methylphenidate—Vomiting—Methylprednisolone—asthma	7.56e-06	6.92e-05	CcSEcCtD
Methylphenidate—Nausea—Hydrocortisone—asthma	7.52e-06	6.88e-05	CcSEcCtD
Methylphenidate—Rash—Triamcinolone—asthma	7.51e-06	6.87e-05	CcSEcCtD
Methylphenidate—Dermatitis—Triamcinolone—asthma	7.5e-06	6.87e-05	CcSEcCtD
Methylphenidate—Rash—Methylprednisolone—asthma	7.49e-06	6.86e-05	CcSEcCtD
Methylphenidate—Dermatitis—Methylprednisolone—asthma	7.49e-06	6.85e-05	CcSEcCtD
Methylphenidate—Urticaria—Prednisone—asthma	7.48e-06	6.84e-05	CcSEcCtD
Methylphenidate—Headache—Triamcinolone—asthma	7.46e-06	6.83e-05	CcSEcCtD
Methylphenidate—Headache—Methylprednisolone—asthma	7.45e-06	6.82e-05	CcSEcCtD
Methylphenidate—Abdominal pain—Prednisone—asthma	7.44e-06	6.81e-05	CcSEcCtD
Methylphenidate—Body temperature increased—Prednisone—asthma	7.44e-06	6.81e-05	CcSEcCtD
Methylphenidate—Diarrhoea—Betamethasone—asthma	7.4e-06	6.77e-05	CcSEcCtD
Methylphenidate—Diarrhoea—Dexamethasone—asthma	7.4e-06	6.77e-05	CcSEcCtD
Methylphenidate—Dizziness—Dexamethasone—asthma	7.15e-06	6.54e-05	CcSEcCtD
Methylphenidate—Dizziness—Betamethasone—asthma	7.15e-06	6.54e-05	CcSEcCtD
Methylphenidate—Nausea—Triamcinolone—asthma	7.08e-06	6.48e-05	CcSEcCtD
Methylphenidate—Nausea—Methylprednisolone—asthma	7.06e-06	6.46e-05	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisone—asthma	6.94e-06	6.35e-05	CcSEcCtD
Methylphenidate—Vomiting—Dexamethasone—asthma	6.87e-06	6.29e-05	CcSEcCtD
Methylphenidate—Vomiting—Betamethasone—asthma	6.87e-06	6.29e-05	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—VEGFA—asthma	6.85e-06	0.00227	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—CARM1—asthma	6.83e-06	0.00226	CbGpPWpGaD
Methylphenidate—Rash—Betamethasone—asthma	6.82e-06	6.24e-05	CcSEcCtD
Methylphenidate—Rash—Dexamethasone—asthma	6.82e-06	6.24e-05	CcSEcCtD
Methylphenidate—Dermatitis—Dexamethasone—asthma	6.81e-06	6.23e-05	CcSEcCtD
Methylphenidate—Dermatitis—Betamethasone—asthma	6.81e-06	6.23e-05	CcSEcCtD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—asthma	6.77e-06	0.00225	CbGpPWpGaD
Methylphenidate—Headache—Betamethasone—asthma	6.77e-06	6.2e-05	CcSEcCtD
Methylphenidate—Headache—Dexamethasone—asthma	6.77e-06	6.2e-05	CcSEcCtD
Methylphenidate—Asthenia—Prednisone—asthma	6.75e-06	6.18e-05	CcSEcCtD
Methylphenidate—Pruritus—Prednisone—asthma	6.66e-06	6.1e-05	CcSEcCtD
Methylphenidate—SLC6A4—NRF2 pathway—TGFB1—asthma	6.63e-06	0.0022	CbGpPWpGaD
Methylphenidate—Diarrhoea—Prednisone—asthma	6.44e-06	5.89e-05	CcSEcCtD
Methylphenidate—Nausea—Dexamethasone—asthma	6.42e-06	5.88e-05	CcSEcCtD
Methylphenidate—Nausea—Betamethasone—asthma	6.42e-06	5.88e-05	CcSEcCtD
Methylphenidate—Dizziness—Prednisone—asthma	6.22e-06	5.7e-05	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—PTEN—asthma	6.19e-06	0.00205	CbGpPWpGaD
Methylphenidate—Vomiting—Prednisone—asthma	5.99e-06	5.48e-05	CcSEcCtD
Methylphenidate—Rash—Prednisone—asthma	5.94e-06	5.43e-05	CcSEcCtD
Methylphenidate—Dermatitis—Prednisone—asthma	5.93e-06	5.43e-05	CcSEcCtD
Methylphenidate—Headache—Prednisone—asthma	5.9e-06	5.4e-05	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—TNF—asthma	5.87e-06	0.00195	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—ADCY2—asthma	5.72e-06	0.0019	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—TGFB1—asthma	5.7e-06	0.00189	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—ALB—asthma	5.68e-06	0.00188	CbGpPWpGaD
Methylphenidate—Nausea—Prednisone—asthma	5.59e-06	5.12e-05	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—GSTP1—asthma	5.54e-06	0.00184	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—GSTP1—asthma	5.46e-06	0.00181	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—GSTM1—asthma	5.09e-06	0.00169	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—ADCY2—asthma	5.07e-06	0.00168	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—TGFB1—asthma	5.05e-06	0.00167	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—ALB—asthma	5.03e-06	0.00167	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—GSTM1—asthma	5.02e-06	0.00166	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—HMOX1—asthma	4.81e-06	0.00159	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL6—asthma	4.74e-06	0.00157	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—HMOX1—asthma	4.26e-06	0.00141	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—IL6—asthma	3.87e-06	0.00128	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—POMC—asthma	3.6e-06	0.00119	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LTC4S—asthma	3.39e-06	0.00112	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LTA4H—asthma	2.94e-06	0.000975	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—ALB—asthma	2.89e-06	0.000957	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ARG1—asthma	2.57e-06	0.000853	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—ALB—asthma	2.56e-06	0.000848	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALDH7A1—asthma	2.33e-06	0.000771	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ARG2—asthma	2.23e-06	0.000739	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALOX5AP—asthma	1.85e-06	0.000613	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALOX15—asthma	1.85e-06	0.000613	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CHAT—asthma	1.76e-06	0.000584	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALOX5—asthma	1.57e-06	0.000521	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CARM1—asthma	1.5e-06	0.000497	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—DCN—asthma	1.48e-06	0.00049	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALDH2—asthma	1.44e-06	0.000476	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GSTT1—asthma	1.37e-06	0.000453	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NQO1—asthma	1.14e-06	0.000377	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ADCY2—asthma	1.11e-06	0.000368	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GSTP1—asthma	9.47e-07	0.000314	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HMOX1—asthma	9.34e-07	0.00031	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ITPR1—asthma	9.32e-07	0.000309	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CAT—asthma	9.22e-07	0.000306	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GSTM1—asthma	8.71e-07	0.000289	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PLA2G4A—asthma	8.71e-07	0.000289	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPP2CA—asthma	8.02e-07	0.000266	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—POMC—asthma	6.15e-07	0.000204	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALB—asthma	5.61e-07	0.000186	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NOS3—asthma	5.37e-07	0.000178	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PTGS2—asthma	4.91e-07	0.000163	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PTEN—asthma	4.28e-07	0.000142	CbGpPWpGaD
